Last updated on May 2019

Study Evaluating KTE-C19 in Pediatric and Adolescent Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia


Brief description of study

The primary objectives of this study are to evaluate the safety and efficacy of KTE-C19 in pediatric and adolescent participants with relapsed/refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL).

Clinical Study Identifier: NCT02625480

Find a site near you

Start Over

Children's Hospitals and Clinics of Minnesota

Minneapolis, MN United States
1.24miles
  Connect »